Nu Skin Enterprises (NYSE:NUS – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday.
Several other analysts have also recently commented on NUS. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Saturday, September 27th. Zacks Research upgraded shares of Nu Skin Enterprises to a “hold” rating in a research report on Tuesday, August 12th. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Hold” and a consensus target price of $6.88.
Check Out Our Latest Report on Nu Skin Enterprises
Nu Skin Enterprises Stock Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.25 by $0.18. The company had revenue of $386.14 million during the quarter, compared to analysts’ expectations of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, equities research analysts predict that Nu Skin Enterprises will post 1.05 EPS for the current year.
Insider Buying and Selling
In other news, Director Daniel W. Campbell sold 23,391 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the transaction, the director directly owned 53,375 shares in the company, valued at $645,837.50. This represents a 30.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Chayce David Clark sold 20,000 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the transaction, the executive vice president owned 233,140 shares of the company’s stock, valued at approximately $2,790,685.80. This represents a 7.90% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 58,926 shares of company stock valued at $711,364. Company insiders own 2.00% of the company’s stock.
Institutional Investors Weigh In On Nu Skin Enterprises
Several hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC lifted its stake in Nu Skin Enterprises by 63.5% in the 3rd quarter. GAMMA Investing LLC now owns 3,036 shares of the company’s stock valued at $37,000 after purchasing an additional 1,179 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of Nu Skin Enterprises by 28.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company’s stock worth $55,000 after purchasing an additional 1,768 shares during the period. PAX Financial Group LLC increased its holdings in shares of Nu Skin Enterprises by 5.0% during the first quarter. PAX Financial Group LLC now owns 38,473 shares of the company’s stock worth $279,000 after purchasing an additional 1,840 shares during the period. SummerHaven Investment Management LLC increased its holdings in shares of Nu Skin Enterprises by 2.8% during the first quarter. SummerHaven Investment Management LLC now owns 79,860 shares of the company’s stock worth $580,000 after purchasing an additional 2,195 shares during the period. Finally, Inspire Investing LLC increased its holdings in shares of Nu Skin Enterprises by 4.8% during the second quarter. Inspire Investing LLC now owns 48,794 shares of the company’s stock worth $390,000 after purchasing an additional 2,250 shares during the period. 82.84% of the stock is currently owned by institutional investors and hedge funds.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
- Five stocks we like better than Nu Skin Enterprises
- What is a penny stock? A comprehensive guide
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.